Table 1 Five-year relative survival at diagnosis and 5- and 10-years post-diagnosis among adult patients with nodular lymphocyte‐predominant Hodgkin lymphoma in the Netherlands according to baseline characteristics, 1993–2018.
Characteristics | No. of patients at diagnosis | No. of patients at risk under the hybrid approach after x year | Conditional 5-year relative survival (95% CI) | |||||
|---|---|---|---|---|---|---|---|---|
N | (%) | 0 | 5 | 10 | At diagnosis | At 5 years | At 10 years | |
Total no. of patients | 747 | – | 729 | 475 | 292 | 93 (90–96) | 99 (96–101) | 93 (87–96) |
Sex | ||||||||
Male | 555 | (74) | 542 | 355 | 226 | 93 (90–96) | 99 (96–102) | 93 (88–98) |
Female | 192 | (26) | 187 | 120 | 66 | 95 (90–100) | 99 (94–104) | 90 (80–102) |
Age at diagnosis | ||||||||
18–44 years | 379 | (51) | 372 | 274 | 190 | 98 (96–100) | 100 (99–101) | 96 (92–100) |
≥45 years | 368 | (49) | 357 | 201 | 102 | 89 (85–94) | 97 (91–103) | 86 (75–98) |
Stage at diagnosis | ||||||||
I–II | 526 | (70) | 515 | 362 | 237 | 98 (95–100) | 101 (99–103) | 94 (89–99) |
III–IV | 206 | (28) | 201 | 102 | 47 | 85 (79–92) | 92 (83–101) | 88 (75–103) |
Unknown | 15 | (2) | 13 | 11 | 8 | ─a | ─a | ─a |
